Thorough QT Study of Nelfinavir

Completed · Phase 4

Conditions studied: Healthy Volunteers

In brief

To assess if nelfinavir has any clinically meaninful effect on cardiac function, namely ECG evaluation

Key facts

Study ID

NCT00312182

Run by

Pfizer

People needed

68

Starts

2006-03-01

Expected to finish

2006-06-01

Last updated by the study team

2009-04-10

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subjects between the ages of 18 and 55 years, inclusive. Body Mass Index (BMI) of approximately 18 to 30 kg/m2.

You may not qualify if…

• Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States
• Pfizer Investigational Site — Ann Arbor, Michigan, United States
• Pfizer Investigational Site — Brussels, Belgium
• Pfizer Investigational Site — Singapore, Singapore

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.